NCT06571409已完成不适用
Clinical Evaluation of the Efficacy of a Dietary Supplement Claiming Anti-aging Properties and UV-protection in Healthy Adults: a Randomized, Double-blind, Placebo Controlled, Parallel, Clinical Trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Seppic
- 入组人数
- 99
- 试验地点
- 2
- 主要终点
- Skin profilometry
研究概览
简要总结
The study aims to assess the anti-aging and photoprotective efficacy of two active concentrations of a food supplement composed of Coriander Seed Oil (CSO).
详细描述
A double blind, parallel groups, placebo-controlled study is carried out on 90 female subjects aged between 35 and 65 years old with visible Crow's feet wrinkles and mild to moderate skin slackness.
The study foresees 56 days of products intake. Evaluations of the parameters under study are performed at baseline, after 14, 28 and 56 days of products consumption.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 35 Years 至 65 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Healthy female subjects
- •Caucasian ethnicity
- •Age between 35 and 65 years old (extremes included)
- •Phototype I to III (with all skin types without any specific repartition)
- •Visible Crow's feet wrinkles (> 2 according to Skin Aging Atlas - Caucasian Type - Bazin Roland) and mild to moderate skin slackness at cheek level (grade 1-3 - internal clinical scale)
- •Subjects who have not been recently involved in any other similar study (at least 1 month of wash-out)
- •Subjects registered with health social security or health social insurance
- •Subjects having signed the Informed Consent Form (ICF) and Privacy Policy for their participation in the study and a photograph authorization
- •Subjects able to understand the language used in the investigation center and the information given
- •Subjects able to comply with the protocol and follow protocol constraints and specific requirements
- •Willingness to use during all the study period only the product to be tested
- •Willingness not to use similar products that could interfere with the expected product effect to be tested (e.g. with antiaging or soothing or UV protection efficacy)
- •Willingness to not vary the normal daily routine (i.e. lifestyle, physical activity, diet etc.)
- •Subjects under effective contraception (oral/not oral) if women of childbearing potential; not expected to be changed during the trial
- •Subjects who have not sun exposure (both natural or artificial) for at least two months
- •Subjects who accept not to expose in intensive way to UV rays during the whole study duration
- •Subjects who have not been involved in any sun test (for SPF evaluation) or tests that provide skin irradiation since less than two months
排除标准
- •Subject is taking part or planning to participate to another clinical study in the same or in another investigation center
- •Subject who is deprived of freedom by administrative or legal decision or under guardianship
- •Subject admitted in a sanitary or social facilities
- •Subject who is planning an hospitalization during the study
- •Subjects under treatment with food supplements which could interfere with the functionality of the product under study
- •Subject breastfeeding, pregnant or not willing to take necessary precautions to avoid pregnancy during the study (if women of childbearing potential)
- •Subject has started or changed estrogen-progesterone contraception or hormonal treatment, within the 3 months prior to the study or foreseeing it for the duration of the study
- •Subject having an acute, chronic or progressive illness liable to interfere with the study data or considered by the Investigator hazardous for the subject or incompatible with the study requirements
- •Subjects under radiotherapy, chemotherapy at any time
- •Subject having a skin condition liable to interfere with the study data or considered by the Investigator hazardous for the subject or incompatible with the study requirements
- •Pharmacological treatments (topic or systemic) known to interfere with skin metabolism/physiology
- •Subjects under locally pharmacological/non-pharmacological treatment applied on the skin area monitored during the test
- •Subject with known or suspected sensitization to one or more test formulation ingredients
- •Subjects considered as not adequate to participate to the study by the investigator
- •Adult protected by law (under control or hospitalized in public or private institutions for reasons other than research, or incarcerated)
- •Subjects not able to communicate or cooperate with the investigator for problems related to language, mental retardation or impaired brain function
结局指标
主要结局
Skin profilometry
时间窗: 56 days
Primos 3D
次要结局
- Skin elasticity(56 days)
- Self-assessment of product efficacy(56 days)
- Erythema index(56 days)
- Transepidermal water loss(56 days)
- Skin inflammation (subgroup of 20 subjects)(56 days)
- Skin lipoxidation (subgroup of 20 subjects)(56 days)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
"Visiobiane Anti-age" Effects on Vision ParametersMacular Pigment Optical DensityNCT00449917PiLeJe30
已完成
不适用
Evaluation of the Anti-aging Efficacy of a Novel Skin Health ProductSkin AgingNCT05300984Amazentis SA48
已完成
不适用
Efficacy of a food supplement in protecting the skin from sun and agingMild-to-moderate skin agingSkin and Connective Tissue DiseasesISRCTN89244753BIONAP srl110
Unknown
3 期
Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung CancerNon-small Cell Lung CancerNCT00246727Sun Farm Corporation300
已完成
不适用
Efficacy and Tolerance Evaluation of an Anti-age Food SupplementModerate-severe Skin Aging/PhotoagingNCT03274154Derming SRL66